Employment |
Company: The Chinese University of Hong Kong |
Recipient: You |
|
Leadership |
Company: AstraZeneca |
Recipient: You |
Company: Aurora Tele-Oncology Limited |
Recipient: You |
Company: Lunit |
Recipient: You |
Company: ACT Genomics-Sanomics Group |
Recipient: You |
Company: HUTCHMED |
Recipient: You |
|
Stock and Other Ownership Interests |
Company: Aurora Tele-Oncology Limited |
Recipient: You |
Company: HUTCHMED |
Recipient: You |
Company: ACT Genomics-Sanomics Group |
Recipient: You |
|
Honoraria |
Company: AstraZeneca |
Recipient: You |
Company: Alpha Biopharma |
Recipient: You |
Company: ACEA Pharmaceutical Research |
Recipient: You |
Company: Amgen |
Recipient: You |
Company: Amoy Diagnostics |
Recipient: You |
Company: BeiGene |
Recipient: You |
Company: Boehringer Ingelheim |
Recipient: You |
Company: Bristol-Myers Squibb |
Recipient: You |
Company: Daiichi Sankyo/UCB Japan |
Recipient: You |
Company: Fishawack Facilitate |
Recipient: You |
Company: InMed Medical Communication |
Recipient: You |
Company: Lilly |
Recipient: You |
Company: Merck Sharp & Dohme |
Recipient: You |
Company: Novartis |
Recipient: You |
Company: Origimed |
Recipient: You |
Company: Pfizer |
Recipient: You |
Company: Prime Oncology |
Recipient: You |
Company: Roche |
Recipient: You |
Company: Sanofi Aventis GmbH |
Recipient: You |
Company: Taiho Pharmaceutical |
Recipient: You |
Company: Takeda |
Recipient: You |
Company: Lucence Health Inc. |
Recipient: You |
Company: Medscape |
Recipient: You |
Company: P. Permanyer SL |
Recipient: You |
Company: PeerVoice |
Recipient: You |
Company: Physicans' Education Resource |
Recipient: You |
Company: Research to Practice |
Recipient: You |
Company: Shanghai BeBirds Translation & Consulting Co. |
Recipient: You |
Company: Liangyihui Network Technology Co., Ltd. |
Recipient: You |
Company: Abbvie |
Recipient: You |
Company: Berry Oncology |
Recipient: You |
Company: Blueprint Medicines |
Recipient: You |
Company: C4 Therapeutics |
Recipient: You |
Company: CStone Pharmaceuticals |
Recipient: You |
Company: Curio Science |
Recipient: You |
Company: D3 Bio Ltd. |
Recipient: You |
Company: Eisai |
Recipient: You |
Company: Gilead Sciences |
Recipient: You |
Company: Gritstone Oncology |
Recipient: You |
Company: Guardant Health |
Recipient: You |
Company: touchIME |
Recipient: You |
|
Consulting or Advisory Role |
Company: Abbvie |
Recipient: You |
Company: ACEA Pharmaceutical Research |
Recipient: You |
Company: Alpha Biopharma |
Recipient: You |
Company: Amgen |
Recipient: You |
Company: Amoy Diagnostics |
Recipient: You |
Company: AstraZeneca |
Recipient: You |
Company: BeiGene |
Recipient: You |
Company: Berry Oncology |
Recipient: You |
Company: Boehringer Ingelheim |
Recipient: You |
Company: Blueprint Medicines |
Recipient: You |
Company: Bristol-Myers Squibb |
Recipient: You |
Company: CStone Pharmaceuticals |
Recipient: You |
Company: Curio Science |
Recipient: You |
Company: Daiichi Sankyo/UCB Japan |
Recipient: You |
Company: Eisai |
Recipient: You |
Company: Fishawack Facilitate |
Recipient: You |
Company: Gritstone Oncology |
Recipient: You |
Company: Guardant Health |
Recipient: You |
Company: Hengrui Therapeutics |
Recipient: You |
Company: Ignyta |
Recipient: You |
Company: Incyte Corporation |
Recipient: You |
Company: Inivata |
Recipient: You |
Company: IQvia |
Recipient: You |
Company: Lilly |
Recipient: You |
Company: Loxo-Oncology |
Recipient: You |
Company: Lunit |
Recipient: You |
Company: Merck Serono |
Recipient: You |
Company: Merck Sharp & Dohme |
Recipient: You |
Company: Mirati Therapeutics |
Recipient: You |
Company: Novartis |
Recipient: You |
Company: Pfizer |
Recipient: You |
Company: Puma Biotechnology |
Recipient: You |
Company: Roche |
Recipient: You |
Company: SFJ Pharmaceuticals Group |
Recipient: You |
Company: Takeda |
Recipient: You |
Company: Vertex Pharmaceuticals |
Recipient: You |
Company: Yuhan |
Recipient: You |
Company: Qiming Development (HK) Ltd. |
Recipient: You |
Company: D3 Bio Limited |
Recipient: You |
Company: C4 Therapeutics |
Recipient: You |
Company: G1 Therapeutics |
Recipient: You |
Company: Gilead Sciences |
Recipient: You |
Company: Janssen |
Recipient: You |
Company: geneDecode |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: AstraZeneca |
Recipient: Your Institution |
Company: Boehringer Ingelheim |
Recipient: Your Institution |
Company: Pfizer |
Recipient: Your Institution |
Company: Novartis |
Recipient: Your Institution |
Company: SFJ Pharmaceuticals Group |
Recipient: Your Institution |
Company: Roche |
Recipient: Your Institution |
Company: Merck Sharp & Dohme |
Recipient: Your Institution |
Company: Bristol-Myers Squibb |
Recipient: Your Institution |
Company: Xcovery |
Recipient: Your Institution |
Company: G1 Therapeutics |
Recipient: Your Institution |
Company: Merck Serono |
Recipient: Your Institution |
Company: Takeda |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|